Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them

Details for Australian Patent Application No. 2006201472 (hide)

Owner Les Laboratoires Servier

Inventors Peglion, Jean-Louis; Goument, Bertrand; La Cour, Clotilde Mannoury; Millan, Mark; Dessinges, Aimee

Agent Watermark

Pub. Number AU-B-2006201472

Priority 05.03512 08.04.05 FR

Filing date 7 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 20 January 2011

International Classifications

C07D 311/68 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/453 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/5377 (1970.01)

A61K 31/5513 (1970.01)

A61P 1/00 (1970.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/08 (1970.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (1970.01) Drugs for disorders of the metabolism

A61P 25/00 (1970.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (1970.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 215/42 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 239/02 (1970.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 249/12 (1970.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 295/096 (1970.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 313/08 (1970.01) Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

C07D 319/20 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

27 April 2006 Complete Application Filed

  Priority application(s): 05.03512 08.04.05 FR

26 October 2006 Application Open to Public Inspection

  Published as AU-B-2006201472

20 January 2011 Application Accepted

  Published as AU-B-2006201472

19 May 2011 Standard Patent Sealed

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006201473-Human ion channels

2006201471-Uses of agonists and antagonists to modulate activity of TNF-related molecules